AXSM Axsome Therapeutics, Inc. gains 44% Apr 1, 2019
Developing an oral formulation of an existing therapy for pain and osteoarthritis.http://www.priceseries.com/trade/AXSM-Axsome-Therapeutics-Inc-stock-gains-44-percent-a-Trade-Record-by-priceSeries-2019030620190401.html